Chenghai Liu Selected Research

entecavir

1/2022	Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis.
1/2022	Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores.
9/2020	Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: Study protocol for a single arm clinical objective performance criteria trial.
1/2020	Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chenghai Liu Research Topics

Disease

29	Fibrosis (Cirrhosis) 05/2024 - 09/2002
29	Liver Cirrhosis (Hepatic Cirrhosis) 05/2024 - 01/2008
8	Inflammation (Inflammations) 05/2024 - 01/2010
6	Cholestasis 02/2024 - 04/2022
6	Chronic Hepatitis B 11/2023 - 05/2017
6	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 08/2011
6	Liver Diseases (Liver Disease) 09/2023 - 01/2013
4	Necrosis 09/2023 - 01/2010
3	Neoplasms (Cancer) 01/2020 - 08/2011
2	Thrombosis (Thrombus) 05/2024 - 01/2024
2	Chemical and Drug Induced Liver Injury 02/2024 - 01/2021
2	Hepatitis B 11/2023 - 05/2017
2	Ascites 01/2020 - 09/2019
1	Hepatitis 02/2024
1	Jaundice (Icterus) 09/2023
1	Intrahepatic Cholestasis 09/2023
1	Rheumatoid Arthritis 01/2023
1	Digestive System Diseases 01/2023
1	Infarction (Infarctions) 01/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Fatigue 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Infections 01/2022
1	Ureteral Obstruction 01/2022

Drug/Important Bio-Agent (IBA)

11	fuzheng huayuIBA 01/2024 - 06/2009
7	Carbon Tetrachloride (Tetrachloromethane)IBA 05/2024 - 12/2010
7	CollagenIBA 05/2024 - 01/2010
7	Dimethylnitrosamine (Nitrosodimethylamine)IBA 02/2021 - 01/2008
5	Antiviral Agents (Antivirals)IBA 11/2023 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2010
4	Therapeutic UsesIBA 02/2024 - 01/2008
4	entecavir FDA Link 01/2022 - 01/2020
4	Huang QiIBA 07/2015 - 01/2008
3	Hydroxyproline (4 Hydroxyproline)IBA 05/2024 - 01/2014
3	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2020
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 03/2014
3	salvianolic acid BIBA 01/2012 - 09/2002
2	AnticoagulantsIBA 05/2024 - 01/2024
2	Glycyrrhetinic Acid (Po 12)IBA 02/2024 - 12/2023
2	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 02/2024 - 01/2023
2	Caspase 8 (Caspase-8)IBA 12/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2022
2	Cholic AcidIBA 09/2023 - 01/2023
2	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2023
2	ursodoxicoltaurineIBA 01/2023 - 01/2023
2	Antifibrotic AgentsIBA 01/2022 - 09/2020
2	Tenofovir (Viread)FDA Link 01/2022 - 01/2020
2	xiaozhang tieIBA 01/2020 - 09/2019
2	AngiotensinsIBA 01/2020 - 11/2016
2	Angiotensin IIIBA 11/2016 - 01/2012
2	huangqi decoctionIBA 07/2015 - 04/2012
2	Hematoxylin (Haematoxylon)IBA 02/2015 - 03/2014
2	yinchenhaoIBA 09/2008 - 01/2008
1	RivaroxabanIBA 05/2024
1	Antitubercular AgentsIBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 02/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024
1	Cycloheximide (Cicloheximide)IBA 02/2024
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2024
1	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 01/2024
1	InflammasomesIBA 01/2024
1	Warfarin (Coumadin)FDA LinkGeneric 01/2024
1	Bile Acids and Salts (Bile Acids)IBA 09/2023
1	yinchenIBA 09/2023
1	EnzymesIBA 09/2023
1	Transaminases (Aminotransferases)IBA 09/2023
1	ErbB Receptors (EGF Receptor)IBA 07/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	celastrolIBA 01/2023
1	triptotriterpenic acid AIBA 01/2023
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2023
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2023
1	isothiocyanic acidIBA 01/2023
1	obeticholic acidIBA 01/2023
1	CaspasesIBA 01/2023
1	Taurocholic Acid (Sodium Taurocholate)IBA 04/2022
1	aristolochic acid I (aristolochic acid)IBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Nonprescription Drugs (Patent Medicines)IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Laminin (Merosin)IBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Fluconazole (Zonal)FDA LinkGeneric 01/2022
1	indium-bleomycinIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Mercuric Chloride (Sublimate)IBA 01/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	CreatinineIBA 01/2022
1	NitrogenIBA 01/2022

Therapy/Procedure

11	Therapeutics 01/2024 - 01/2016
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 01/2012
2	Ligation 05/2024 - 07/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
2	Intraperitoneal Injections 09/2019 - 01/2013
1	Liver Transplantation 11/2023